A multicentre Italian cohort study found that patients receiving brodalumab for moderate-to-severe plaque psoriasis achieved a median 97.4 percent normalized ...
A multicenter cohort study identifies early biologic therapy, lower body mass index, and fewer baseline tunnels as key predictors of ...
A cross-sectional study finds that Multi-Inflammatory Indices do not significantly distinguish active from inactive ankylosing spondylitis disease states, though they ...
A study of 137 patients found that anti-drug antibodies are associated with lower adalimumab levels and higher disease activity in ...
A 52-week prospective real-world study found that switching to tildrakizumab after anti-IL-17 failure led to sustained clinical improvement and quality ...
A prospective registry study in Austria found that severe asthma patients experienced significant improvements in asthma control and lung function ...
A new multiomics-clinical model predicts which psoriasis patients will achieve a 75% reduction in disease severity, identifying HLA-Cw6 genotype and ...
A real-world study finds mepolizumab is associated with reduced healthcare visits and improved symptoms in patients with chronic rhinosinusitis with ...
A German registry study reveals that adult familial Mediterranean fever patients homozygous for the M694V mutation experience earlier symptom onset ...
A retrospective cohort study of 49 severe asthma patients eligible for both biologics found mepolizumab cut clinically significant exacerbations by ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
